LGND Forecast



BearishBullish



80% Confidence




Bullish Case: LGND return-surface density centers on small positives, while the IV surface shows mostly contained mid-strike vols and extreme risk concentrated in far-low-strike puts. Prior mean-reversion calls have matched the flat tape into June. With Helium bullish risk (+31%) and a +2.33% AI drift, the higher-likelihood path is a modest grind up. Near-term call activity (06/18 260C) fits a pin above ~255–265 unless a headline hits.




Bearish Case: Backwardation and the LGND vol-surface “red” wedge at deep put strikes imply market hedges for a rare idiosyncratic shock, not a broad SPY-style move (SPY IV surface smoother/lower). Prior downside odds (~12%) didn’t realize into June, but the tail premium remains. If a negative SEC/regulatory/royalty surprise arrives around 6/18 (gamma window), price could reprice sharply lower.




Potential Outcomes:
  1. 18%: +6–15% if a royalty/milestone/guidance beat lands (test: bullish PR + rising call OI) in 2–6w.
  2. 52%: -3%..+5% drift/mean reversion (test: quiet headlines) into next months.
  3. 15%: IV unwind w/ price within ±2% (test: term structure stops backwardating after 6/18).
  4. 12%: -25–45% crash on SEC/regulatory/short-report (test: negative headline + fast put buying within 48h).
  5. 3%: -8–15% from broad risk-off.
Known: price flat; Inferred: idio tail from LGND put-IV skew; Uncertain: timing. Oracle: call-spread tilt; tail-hedge.



June 17, 2026


Ligand Pharmaceuticals Forecast

LGND        Ligand Pharmaceuticals

20 Day Price Forecast + Forecast Track Record.  (?)

36 Day Price Forecast + Forecast Track Record.  (?)

49 Day Price Forecast + Forecast Track Record.  (?)

















Become a more profitable trader with AI optimized trading strategies